Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 123

Cited In for PubMed (Select 16287954)

1.

Baseline diabetes as a way to predict CV outcomes in a lipid-modifying trial: a meta-analysis of 330,376 patients from 47 landmark studies.

Hermans MP, Bouenizabila E, Amoussou-Guenou DK, Ahn SA, Rousseau MF.

Cardiovasc Diabetol. 2015 May 21;14:60. doi: 10.1186/s12933-015-0226-z.

2.

Combination therapy analysis of ezetimibe and statins in Chinese patients with acute coronary syndrome and type 2 diabetes.

Li L, Zhang M, Su F, Li Y, Shen Y, Shen J, Zhang D.

Lipids Health Dis. 2015 Feb 18;14:10. doi: 10.1186/s12944-015-0004-7.

3.

Consensus statement on management of dyslipidemia in Indian subjects.

Chandra KS, Bansal M, Nair T, Iyengar SS, Gupta R, Manchanda SC, Mohanan PP, Rao VD, Manjunath CN, Sawhney JP, Sinha N, Pancholia AK, Mishra S, Kasliwal RR, Kumar S, Krishnan U, Kalra S, Misra A, Shrivastava U, Gulati S.

Indian Heart J. 2014 Dec;66 Suppl 3:S1-51. doi: 10.1016/j.ihj.2014.12.001. Epub 2014 Dec 24. No abstract available.

4.

Clinical Effects of Portulaca Oleracea Seeds on Dyslipidemia in Obese Adolescents: a Triple-blinded Randomized Controlled Trial.

Sabzghabaee AM, Kelishadi R, Jelokhanian H, Asgary S, Ghannadi A, Badri S.

Med Arch. 2014 Jun;68(3):195-9. doi: 10.5455/medarh.2014.68.195-199. Epub 2014 May 31.

5.

Statins: definitive translational research.

Grundy SM.

Mol Med. 2014 Dec 16;20 Suppl 1:S20-3. doi: 10.2119/molmed.2014.00194. No abstract available.

6.

Lipid-lowering activity of Cow urine ark in guinea pigs fed with a high cholesterol diet.

Manubhai CH, Rasiklal MD, Natvarlal BS, Kishorbhai VV, Rajkishor TC.

Avicenna J Phytomed. 2014 Sep;4(5):354-63.

8.

National trends in recurrent AMI hospitalizations 1 year after acute myocardial infarction in Medicare beneficiaries: 1999-2010.

Chaudhry SI, Khan RF, Chen J, Dharmarajan K, Dodson JA, Masoudi FA, Wang Y, Krumholz HM.

J Am Heart Assoc. 2014 Sep 23;3(5):e001197. doi: 10.1161/JAHA.114.001197. Erratum in: J Am Heart Assoc. 2014 Dec;3(6):e000522.

9.

Clinician's guide to the updated ABCs of cardiovascular disease prevention.

Kohli P, Whelton SP, Hsu S, Yancy CW, Stone NJ, Chrispin J, Gilotra NA, Houston B, Ashen MD, Martin SS, Joshi PH, McEvoy JW, Gluckman TJ, Michos ED, Blaha MJ, Blumenthal RS.

J Am Heart Assoc. 2014 Sep 22;3(5):e001098. doi: 10.1161/JAHA.114.001098.

10.

Estimates of commercial population at high risk for cardiovascular events: impact of aggressive cholesterol reduction.

Fitch K, Goldberg SW, Iwasaki K, Pyenson BS, Kuznik A, Solomon HA.

Am Health Drug Benefits. 2009 Sep;2(6):224-32.

11.

Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trials.

Boekholdt SM, Hovingh GK, Mora S, Arsenault BJ, Amarenco P, Pedersen TR, LaRosa JC, Waters DD, DeMicco DA, Simes RJ, Keech AC, Colquhoun D, Hitman GA, Betteridge DJ, Clearfield MB, Downs JR, Colhoun HM, Gotto AM Jr, Ridker PM, Grundy SM, Kastelein JJ.

J Am Coll Cardiol. 2014 Aug 5;64(5):485-94. doi: 10.1016/j.jacc.2014.02.615. Review.

12.

Mechanisms and assessment of statin-related muscular adverse effects.

Moßhammer D, Schaeffeler E, Schwab M, Mörike K.

Br J Clin Pharmacol. 2014 Sep;78(3):454-66. doi: 10.1111/bcp.12360. Review.

PMID:
25069381
13.

Atherosclerotic Cardiovascular Disease Risk and Evidence-based Management of Cholesterol.

Roy S.

N Am J Med Sci. 2014 May;6(5):191-8. doi: 10.4103/1947-2714.132916. Review.

14.

Global perspective on acute coronary syndrome: a burden on the young and poor.

Vedanthan R, Seligman B, Fuster V.

Circ Res. 2014 Jun 6;114(12):1959-75. doi: 10.1161/CIRCRESAHA.114.302782. Erratum in: Circ Res. 2014 Aug 1;115(4):e8.

15.

Higher potency statins and the risk of new diabetes: multicentre, observational study of administrative databases.

Dormuth CR, Filion KB, Paterson JM, James MT, Teare GF, Raymond CB, Rahme E, Tamim H, Lipscombe L; Canadian Network for Observational Drug Effect Studies Investigators.

BMJ. 2014 May 29;348:g3244. doi: 10.1136/bmj.g3244.

16.
17.

Sequential cohort design applying propensity score matching to analyze the comparative effectiveness of atorvastatin and simvastatin in preventing cardiovascular events.

Helin-Salmivaara A, Lavikainen P, Aarnio E, Huupponen R, Korhonen MJ.

PLoS One. 2014 Mar 10;9(3):e90325. doi: 10.1371/journal.pone.0090325. eCollection 2014.

18.

Baseline elevated Lp-PLA2 is associated with increased risk for re-stenosis after stent placement.

Zheng D, Zeng F, Cai A, Liao H, Liu L, Qiu R, Xu R, Xiao C, Mai W.

Lipids Health Dis. 2014 Mar 1;13:41. doi: 10.1186/1476-511X-13-41.

19.

Patterns and predictors of intensive statin therapy among patients with diabetes mellitus after acute myocardial infarction.

Abdallah MS, Kosiborod M, Tang F, Karrowni WY, Maddox TM, McGuire DK, Spertus JA, Arnold SV.

Am J Cardiol. 2014 Apr 15;113(8):1267-72. doi: 10.1016/j.amjcard.2013.12.040. Epub 2014 Jan 31.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk